AstraZeneca Results Presentation Deck

Hind CELL THERAPY 26 NOVEL ADCs CEO Opening Remarks AstraZeneca - building the pipeline of the future Delivering sustainable, industry-leading growth 7 ADC = antibody drug conjugate; 10 = immuno-oncology; RNA = ribonucleic acid. DOT GENE THERAPY Financial Results IO BISPECIFICS XX Oncology EPIGENETICS NAN S BioPharmaceuticals OLIGONUCLEOTIDES Rare Disease * T-CELL ENGAGERS RNA THERAPIES CEO Closing Remarks Therapy area leadership, broad pipeline and focused investment to deliver transformative new medicines

View entire presentation